novo nordisk stock ozempic - Search News

An Ozempic alternative shows promising weight loss results

Fortune on MSN · 2d

Novo Nordisk stock surges 7% after Ozempic maker’s latest weight-loss drug shows promise

The new treatment targets gut hormone GLP-1 but also mimics amylin, a hormone released by the pancreas that suppresses hunger.

Investopedia on MSN · 3d

Novo Nordisk Stock Jumps on Early Stage Weight-Loss Drug Trial Results

Novo Nordisk's U.S.-listed shares are surging 9% Friday morning after the Danish drugmaker reported early stage results for its amycretin weight-loss drug.

MarketWatch on MSN · 3d

Ozempic maker’s stock surges. A trial of a new Novo Nordisk drug shows promise.

Novo Nordisk shares jumped on Friday as the Danish drugmaker said an experimental drug was able to reduce weight by as much as 22%.

6don MSN

Will Medicare End Ozempic Maker Novo Nordisk's Obesity Drug Boom?

Just how much Medicare price negotiations will negatively impact Novo Nordisk, though, depends on what the final negotiated ...

9don MSN

Novo Nordisk stock prices drop after Biden lists Ozempic for price negotiations

Stock prices for Novo Nordisk fell by about 3% at market open after the Biden administration selected its revolutionary drugs ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results